Imricor Medical Systems, Inc. (ASX:IMR)
1.380
-0.095 (-6.44%)
Mar 31, 2025, 4:10 PM AEST
Imricor Medical Systems Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
Cash & Equivalents | 15.71 | 0.83 | 5.69 | 18.52 | 25.14 | Upgrade
|
Cash & Short-Term Investments | 15.71 | 0.83 | 5.69 | 18.52 | 25.14 | Upgrade
|
Cash Growth | 1789.04% | -85.38% | -69.28% | -26.35% | 397.93% | Upgrade
|
Receivables | 0.35 | 0.39 | 0.13 | 0.09 | 0.22 | Upgrade
|
Inventory | 1.5 | 1.68 | 2.28 | 2.58 | 3.07 | Upgrade
|
Prepaid Expenses | 0.79 | 1.03 | 1.59 | 1.51 | 0.49 | Upgrade
|
Total Current Assets | 18.35 | 3.94 | 9.68 | 22.7 | 28.92 | Upgrade
|
Property, Plant & Equipment | 2.6 | 3.17 | 3.56 | 3.6 | 3.89 | Upgrade
|
Other Long-Term Assets | 0.68 | 1.2 | 0.46 | 0.57 | 0.75 | Upgrade
|
Total Assets | 21.62 | 8.31 | 13.7 | 26.86 | 33.57 | Upgrade
|
Accounts Payable | 0.33 | 2.1 | 0.26 | 0.69 | 0.53 | Upgrade
|
Accrued Expenses | 1.49 | 0.79 | 0.92 | 1.35 | 1.07 | Upgrade
|
Short-Term Debt | - | 0.36 | - | - | - | Upgrade
|
Current Portion of Leases | 0.47 | 0.73 | 0.87 | 0.52 | 0.66 | Upgrade
|
Current Unearned Revenue | 0.06 | 0.58 | 0.02 | 0.18 | 0.04 | Upgrade
|
Total Current Liabilities | 2.36 | 4.57 | 2.07 | 2.74 | 2.3 | Upgrade
|
Long-Term Debt | 19.87 | 8.49 | 2.18 | - | - | Upgrade
|
Long-Term Leases | 0.88 | 1.14 | 1.4 | 1.22 | 1.84 | Upgrade
|
Long-Term Unearned Revenue | 1.1 | 0.79 | 0.49 | 0.51 | 0.55 | Upgrade
|
Other Long-Term Liabilities | 4.8 | 2.08 | 0.04 | - | 0.07 | Upgrade
|
Total Liabilities | 29 | 17.06 | 6.19 | 4.46 | 4.75 | Upgrade
|
Common Stock | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 134.88 | 103.82 | 97.46 | 94.99 | 81.68 | Upgrade
|
Retained Earnings | -142.28 | -112.59 | -89.96 | -72.6 | -52.87 | Upgrade
|
Shareholders' Equity | -7.38 | -8.75 | 7.51 | 22.4 | 28.82 | Upgrade
|
Total Liabilities & Equity | 21.62 | 8.31 | 13.7 | 26.86 | 33.57 | Upgrade
|
Total Debt | 21.21 | 10.71 | 4.45 | 1.74 | 2.5 | Upgrade
|
Net Cash (Debt) | -5.51 | -9.88 | 1.24 | 16.78 | 22.64 | Upgrade
|
Net Cash Growth | - | - | -92.60% | -25.90% | 635.92% | Upgrade
|
Net Cash Per Share | -0.02 | -0.06 | 0.01 | 0.13 | 0.21 | Upgrade
|
Filing Date Shares Outstanding | 270.18 | 168.92 | 151.35 | 143.23 | 125.55 | Upgrade
|
Total Common Shares Outstanding | 270.18 | 168.92 | 151.35 | 143.23 | 125.55 | Upgrade
|
Working Capital | 15.99 | -0.63 | 7.61 | 19.96 | 26.63 | Upgrade
|
Book Value Per Share | -0.03 | -0.05 | 0.05 | 0.16 | 0.23 | Upgrade
|
Tangible Book Value | -7.38 | -8.75 | 7.51 | 22.4 | 28.82 | Upgrade
|
Tangible Book Value Per Share | -0.03 | -0.05 | 0.05 | 0.16 | 0.23 | Upgrade
|
Machinery | 4.11 | 3.84 | 3.47 | 3.28 | 3.28 | Upgrade
|
Leasehold Improvements | 1.64 | 1.64 | 1.64 | 1.6 | 1.46 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.